Detalles de la búsqueda
1.
Range of the perfluorooctanoate (PFOA) safe dose for human health: An international collaboration.
Regul Toxicol Pharmacol
; 145: 105502, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38832926
2.
Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - A case study with parabens.
Regul Toxicol Pharmacol
; 132: 105161, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35508214
3.
Paraquat pharmacokinetics in primates and extrapolation to humans.
Toxicol Appl Pharmacol
; 417: 115463, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631232
4.
Integration of paraquat pharmacokinetic data across species using PBPK modelling.
Toxicol Appl Pharmacol
; 417: 115462, 2021 04 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33631233
5.
Using quantitative modeling tools to assess pharmacokinetic bias in epidemiological studies showing associations between biomarkers and health outcomes at low exposures.
Environ Res
; 197: 111183, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33887277
6.
Kinetics of metabolism of deltamethrin and cis- and trans-permethrin in vitro. Studies using rat and human liver microsomes, isolated rat hepatocytes and rat liver cytosol.
Xenobiotica
; 51(1): 40-50, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757971
7.
New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine.
Regul Toxicol Pharmacol
; 123: 104931, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33905778
8.
Development of a rat and human PBPK model for bromate and estimation of human equivalent concentrations in drinking water.
Int J Environ Health Res
; 31(8): 951-962, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31850798
9.
An updated mode of action and human relevance framework evaluation for Formaldehyde-Related nasal tumors.
Crit Rev Toxicol
; 50(10): 919-952, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33599198
10.
Quantitative bias analysis of the association between subclinical thyroid disease and two perfluoroalkyl substances in a single study.
Environ Res
; 182: 109017, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31865168
11.
Development of a physiologically based pharmacokinetic model of diisononyl phthalate (DiNP) in pregnant rat and human.
J Toxicol Environ Health A
; 83(19-20): 631-648, 2020 10 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-32757748
12.
Extended Analysis and Evidence Integration of Chloroprene as a Human Carcinogen.
Risk Anal
; 40(2): 294-318, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31524302
13.
Updating physiologically based pharmacokinetic models for manganese by incorporating rapid association/dissociation processes in tissues.
Toxicol Appl Pharmacol
; 372: 1-10, 2019 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30978397
14.
Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach.
Crit Rev Toxicol
; 49(1): 36-84, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30932726
15.
Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene.
Inhal Toxicol
; 31(13-14): 468-483, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31992090
16.
An evaluation of the USEPA Proposed Approaches for applying a biologically based dose-response model in a risk assessment for perchlorate in drinking water.
Regul Toxicol Pharmacol
; 103: 237-252, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30707931
17.
Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop.
Regul Toxicol Pharmacol
; 106: 210-223, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31059732
18.
Challenges in working towards an internal threshold of toxicological concern (iTTC) for use in the safety assessment of cosmetics: Discussions from the Cosmetics Europe iTTC Working Group workshop.
Regul Toxicol Pharmacol
; 103: 63-72, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30653989
19.
Physiologically-based pharmacokinetic modeling suggests similar bioavailability of Mn from diet and drinking water.
Toxicol Appl Pharmacol
; 359: 70-81, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30243844
20.
Application of the adverse outcome pathway (AOP) approach to inform mode of action (MOA): A case study with inorganic arsenic.
J Toxicol Environ Health A
; 81(18): 893-912, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30230972